| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer
|
Pfannschmidt, Joachim
|
|
2005
|
49 |
2 |
p. 203-207
5 p.
|
artikel
|
| 2 |
Aims and Scopes
|
|
|
2005
|
49 |
2 |
p. iii-
1 p.
|
artikel
|
| 3 |
Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy
|
Nishio, Makoto
|
|
2005
|
49 |
2 |
p. 245-251
7 p.
|
artikel
|
| 4 |
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer
|
Quoix, Elisabeth
|
|
2005
|
49 |
2 |
p. 253-261
9 p.
|
artikel
|
| 5 |
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America
|
Ho, Cheryl
|
|
2005
|
49 |
2 |
p. 225-231
7 p.
|
artikel
|
| 6 |
Calendar of Events
|
|
|
2005
|
49 |
2 |
p. ix-
1 p.
|
artikel
|
| 7 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy
|
Yamazaki, Shigeo
|
|
2005
|
49 |
2 |
p. 217-223
7 p.
|
artikel
|
| 8 |
Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer
|
Gasinska, Anna
|
|
2005
|
49 |
2 |
p. 171-179
9 p.
|
artikel
|
| 9 |
Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II study
|
Rapti, Ageliki
|
|
2005
|
49 |
2 |
p. 241-244
4 p.
|
artikel
|
| 10 |
Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma
|
Bartling, Babett
|
|
2005
|
49 |
2 |
p. 145-154
10 p.
|
artikel
|
| 11 |
Contents
|
|
|
2005
|
49 |
2 |
p. v-
1 p.
|
artikel
|
| 12 |
Do elderly people with lung cancer benefit from palliative radiotherapy?
|
Turner, N.J.
|
|
2005
|
49 |
2 |
p. 193-202
10 p.
|
artikel
|
| 13 |
HER2/neu intragenic kinase domain mutations may be major determinant of response to trastuzumab or specific kinase inhibitors in non-small cell lung cancer patients
|
Altundag, Ozden
|
|
2005
|
49 |
2 |
p. 279-280
2 p.
|
artikel
|
| 14 |
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia
|
Kennedy, Timothy C.
|
|
2005
|
49 |
2 |
p. 187-191
5 p.
|
artikel
|
| 15 |
Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group
|
Kudoh, S.
|
|
2005
|
49 |
2 |
p. 263-269
7 p.
|
artikel
|
| 16 |
Is the pTNM really pathological?
|
Kużdżał, Jarosław
|
|
2005
|
49 |
2 |
p. 275-276
2 p.
|
artikel
|
| 17 |
Large cell carcinoma of the lung mimicking a germ cell tumor: The potential value of chromosome analysis
|
Ahmed, Syed M.
|
|
2005
|
49 |
2 |
p. 271-274
4 p.
|
artikel
|
| 18 |
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma
|
Wang, Yimin
|
|
2005
|
49 |
2 |
p. 155-161
7 p.
|
artikel
|
| 19 |
Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis
|
Wisnivesky, Juan P.
|
|
2005
|
49 |
2 |
p. 181-186
6 p.
|
artikel
|
| 20 |
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: Contemporary experience from a single institution
|
Giordano, Karin F.
|
|
2005
|
49 |
2 |
p. 209-215
7 p.
|
artikel
|
| 21 |
Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer
|
Tan, E.H.
|
|
2005
|
49 |
2 |
p. 233-240
8 p.
|
artikel
|
| 22 |
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer
|
Mortenson, Melinda M.
|
|
2005
|
49 |
2 |
p. 163-170
8 p.
|
artikel
|
| 23 |
9th Central European Lung Cancer Conference in Gdańsk
|
Skrzypski, Marcin
|
|
2005
|
49 |
2 |
p. 281-284
4 p.
|
artikel
|
| 24 |
Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancer
|
Hotta, Katsuyuki
|
|
2005
|
49 |
2 |
p. 277-
1 p.
|
artikel
|
Tijdschrift beschrijving